Research has demonstrated that higher plasma p-tau levels is linked with reduced cognitive performance in domains such as episodic memory and executive function, reflecting its role in the early detection of AD pathology before clinical symptoms become apparent [86]. Here, MAPT is linked to Alzheimer disease.